Table 2 Characteristics of study population except the primary diagnosis of osteoporotic vertebral fracture

 n of DXA

543

195

272

76

 Age (years)

62.24±7.77

54.82±2.74

63.56±2.81

76.92±5.01

 n of osteoporosis by DXA (n %)

257(47.3%)

43(22.1%)

161(59.2%)

53(69.7%)

<0.001*

 n of osteopenia by DXA (n %)

238(43.8%)

127(65.1%)

96(35.3%)

15(19.7%)

<0.001*

 n of patients with fragility VFs in osteoporosis (n %)

120(46.7%)

8(18.6%)

86(53.4%)

26(49.1%)

<0.001*

 n of patients with fragility VFs in osteopenia (n %)

52(21.8%)

30(23.6%)

21(21.9%)

1(6.7%)

0.168

 n of patients with fragility VFs in normal BMD (n %)

3(6.3%)

1(4.0%)

2(13.3%)

0

 n of osteoporosis by DXA and VRA (n %)

312(57.5%)

74(37.9%)

184(67.6%)

57(71.1%)

<0.001*

 n of DXA

507

216

235

56

 Age (years)

61.47±7.81

54.06±2.88

64.47±2.57

76.13±4.56

 n of osteoporosis by DXA (n %)

74(14.6%)

28(13.0%)

31(13.2%)

15(26.8%)

0.023*

 n of osteopenia by DXA (n %)

240(47.3%)

89(41.2%)

125(53.2%)

26(46.4%)

0.039*

 n of patients with fragility VFs in osteoporosis (n %)

18(24.3%)

4(14.3%)

3(9.8%)

11(73.3%)

<0.001*

 n of patients with fragility VFs in osteopenia (n %)

56(23.3%)

23(25.8%)

28(22.4%)

5(19.2%)

0.828

 n of patients with fragility VFs in normal BMD (n %)

40(20.7%)

21(21.2%)

16(20.3%)

3(20.0%)

 n of osteoporosis by DXA and VRA (n %)

170(33.5%)

72(33.3%)

75(31.9%)

23(41.1%)

0.426